Haemodynamics and left ventricular mass regression: a comparison of the stentless, stented and mechanical aortic valve replacement

European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery
H L ThomsonD J Burstow

Abstract

Our objective was to compare the degree of change in hemodynamics and left ventricular mass (LVM) regression after aortic valve replacement (AVR) with stentless, stented and mechanical valves. Patients greater than 59 years of age had AVR for aortic stenosis with the stentless xenograft (Cryolife-O'Brien, CLOB), stented xenograft (Carpentier-Edwards, C-E) or mechanical valve (ATS). One-hundred and forty-two patients received stentless, 40 stented, and 69 mechanical valves (mean age 74 +/- 6 vs. 72 +/- 7 and 67 +/- 6 years, respectively). Serial echocardiography was performed. The left ventricular outflow tract diameter was similar pre-operatively in the stentless versus the stented versus the mechanical groups (2.2 +/- 0.4 vs. 2.3 +/- 0.2 vs. 2.2 +/- 0.3 cm; P, n.s). The effective orifice area was larger immediately post-operatively in the stentless versus the stented or the mechanical group (2.4 +/- 0.4 vs. 2.0 +/- 0.6 vs. 2.0 +/- 0.7 cm2, P = 0.0001 for both comparisons). The peak aortic gradient at 6 months was significantly less in the stentless versus the stented and mechanical groups (15 +/- 7 vs. 25 +/- 9 vs. 22 +/- 9 mmHg, P < 0.0001). LVM regressed over 6 months in all subgroups: stentless 272 +/- 64 g vs. 220 +/- 72 g...Continue Reading

Citations

Jun 30, 2004·The Annals of Thoracic Surgery·Umesh C SharmaJos G Maessen
Oct 4, 2000·The Annals of Thoracic Surgery·S WestabyG L Grunkemeier
Dec 15, 2005·Heart, Lung & Circulation·M F O'BrienL McLoughlin
Jan 6, 2012·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Jonas Amstrup Funder
Jan 8, 2009·Interactive Cardiovascular and Thoracic Surgery·Petar S RisteskiMirko Doss
Jul 7, 2011·Vascular Health and Risk Management·Junjiro Kobayashi
Aug 10, 1999·Journal of Cardiac Surgery·M F O'BrienD J Burstow
Aug 26, 2014·The Annals of Thoracic Surgery·Markus ThalmannOlaf Stanger
Sep 18, 2007·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·Jagdish ButanyTirone E David
Jan 23, 2003·The Journal of Thoracic and Cardiovascular Surgery·Toshihiro FukuiTakanobu Aoyama
Mar 1, 2005·The Annals of Thoracic Surgery·Mark F O'BrienRichard Slaughter
Nov 26, 2009·The Annals of Thoracic Surgery·Helmut Gulbins, Hermann Reichenspurner
Feb 20, 2007·The Annals of Thoracic Surgery·Edward H KincaidNeal D Kon
Aug 2, 2001·The Journal of Thoracic and Cardiovascular Surgery·F LangerH J Schäfers
Jul 24, 2012·The Journal of Thoracic and Cardiovascular Surgery·Dimitrios C IliopoulosDimitrios Koudoumas
Mar 30, 2001·The Journal of Thoracic and Cardiovascular Surgery·G IsmenoM Cotrufo
Sep 4, 2010·European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology·Odd Bech-HanssenGunnar Svensson
Dec 8, 2016·Asian Cardiovascular & Thoracic Annals·Juergen EnnkerAndreas Boening
Jun 5, 2007·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Michael BeckerRainer Hoffmann
Oct 19, 2005·Circulation·Diego Perez de ArenazaUNKNOWN ASSERT (Aortic Stentless versus Stented valve assessed by Echocardiography Randomized Trial) Investigators
Mar 23, 2018·Frontiers in Surgery·Mustafa ZakkarSerban Stoica
Jun 25, 1999·Current Problems in Surgery·T E David

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.